Monitor share dilution from the equity line facility, as the $10 million raise may involve significant share issuance. Also watch for initiation of OcuRing-K Phase 2 trial, which is a key catalyst. The going concern risk remains active.
Price Chart
Executive Summary
PRF Technologies issued a shareholder letter highlighting a $10 million capital raise from its equity line facility, which strengthened its balance sheet, alongside progress on LayerBio's OcuRing-K Phase 2 preparations and DeepSolar's AI energy platform. The company remains pre-revenue with a going concern warning from its auditor, and the dilution from the equity line offsets the positive financial infusion.
Key Facts
- Raised $10 million through equity line facility on May 28, 2026
- LayerBio advancing preparations for planned Phase 2 trial of OcuRing-K
- PRF-110 preclinical results showed 72-hour analgesic activity comparable to approved benchmark
- DeepSolar validated Predict platform with European data, joined NVIDIA Connect, will showcase GridFeed at Energy Trading Week Europe 2026
- Company has a going concern warning as of the March 2026 20-F filing
Financial Impact
Raised $10 million through equity line facility; no revenue or earnings reported; pre-revenue stage
Risk Factors
- Potential dilution from equity line facility
- Pre-revenue stage with no guaranteed product approval
- Going concern uncertainty persists
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001178913-26-003581 |
| Document: zk2635724.htm | 0001178913-26-003581 |
| Document: 0001178913-26-003581-index-headers.html | 0001178913-26-003581 |
| Document: 0001178913-26-003581-index.html | 0001178913-26-003581 |
| Document: 0001178913-26-003581.txt | 0001178913-26-003581 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | 6-K | $0.7400 | awaiting T+60 | — | $0.7390 (−0.14%) |
Oct 23, 2026 4d ago | Press Release | $0.7400 | awaiting T+60 | — | $0.7390 (−0.14%) |
Sep 28, 2026 29d ago | 6-K | $0.9720 | awaiting T+60 | — | $0.7390 (−23.97%) |
Sep 24, 2026 4w ago | SC 13D | $0.9767 | awaiting T+60 | — | $0.7390 (−24.34%) |
Sep 16, 2026 5w ago | 6-K | $1.01 | awaiting T+60 | — | $0.7390 (−26.83%) |
Sep 4, 2026 7w ago | EFFECT | $0.9680 | awaiting T+60 | — | $0.7390 (+23.66%) |
Sep 3, 2026 7w ago | 6-K | $0.9792 | awaiting T+60 | — | $0.7390 (−24.53%) |
Sep 3, 2026 7w ago | Press Release | $0.9792 | awaiting T+60 | — | $0.7390 (−24.53%) |
Jul 27, 2026 13w ago | 6-K | $1.09 $0.7120 | ▼ −34.68% | ▼ −38.38% | $0.7390 (−32.20%) |
Jul 21, 2026 14w ago | 6-K | $1.20 $0.8180 | ▼ −31.83% | ▼ −35.81% | $0.7390 (−38.42%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers